Skip to content

Esperion Therapeutics, Inc.: filings

Every Esperion Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 52 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-05-08fiscal Q1 202639820001628280-26-032870
10-K2026-03-10fiscal FY 2025501310001628280-26-016522
10-Q2025-11-06fiscal Q3 2025411190001628280-25-050165
10-Q2025-08-13fiscal Q2 2025411150001628280-25-040139
10-Q2025-05-08fiscal Q1 202541850001628280-25-023498
10-K2025-03-07fiscal FY 2024451150001628280-25-011154
10-Q2024-11-07fiscal Q3 2024401170001628280-24-046307
10-Q2024-08-12fiscal Q2 2024411150001628280-24-036762
10-Q2024-05-07fiscal Q1 202442870001628280-24-020862
10-K2024-02-27fiscal FY 202344880001628280-24-007066
10-Q2023-11-07fiscal Q3 2023401190001628280-23-037195
10-Q2023-08-01fiscal Q2 2023401150001628280-23-026358
10-Q2023-05-09fiscal Q1 202340850001628280-23-016646
10-K2023-02-21fiscal FY 202244880001628280-23-004167
10-Q2022-11-01fiscal Q3 2022401190001628280-22-027479
10-Q2022-08-02fiscal Q2 2022401150001628280-22-020111
10-Q2022-05-03fiscal Q1 202238820001628280-22-011885
10-K2022-02-22fiscal FY 2021461190001628280-22-003263
10-Q2021-11-02fiscal Q3 2021401200001628280-21-021092
10-Q2021-08-03fiscal Q2 2021391120001628280-21-015248
10-Q2021-05-04fiscal Q1 202134740001628280-21-008918
10-K2021-02-23fiscal FY 2020461910001628280-21-002865
10-Q2020-11-02fiscal Q3 2020381090001628280-20-015284
10-Q2020-08-10fiscal Q2 2020421150001104659-20-092840
10-Q2020-05-06fiscal Q1 202041830001104659-20-057549
10-K2020-02-27fiscal FY 2019421490001104659-20-026203
10-Q2019-11-06fiscal Q3 201935950001104659-19-060531
10-Q2019-08-08fiscal Q2 2019381000001410578-19-000732
10-Q2019-05-08fiscal Q1 201938750001104659-19-027829
10-K2019-02-28fiscal FY 2018321220001047469-19-000791
10-Q2018-11-01fiscal Q3 201830750001104659-18-065428
10-Q2018-08-02fiscal Q2 201828710001104659-18-049208
10-Q2018-05-02fiscal Q1 201828570001104659-18-029847
10-K2018-02-20fiscal FY 2017321320001047469-18-000899
10-Q2017-11-07fiscal Q3 201730770001104659-17-066648
10-Q2017-08-08fiscal Q2 201729760001104659-17-050245
10-Q2017-05-04fiscal Q1 201725510001104659-17-029916
10-K2017-02-22fiscal FY 2016271180001047469-17-000831
10-Q2016-11-03fiscal Q3 201625670001104659-16-154591
10-Q2016-08-04fiscal Q2 201625670001104659-16-137054
10-Q2016-05-04fiscal Q1 201625500001104659-16-117431
10-K2016-02-25fiscal FY 2015271180001047469-16-010437
10-Q2015-11-05fiscal Q3 201525670001104659-15-076267
10-Q2015-08-06fiscal Q2 201525670001104659-15-057269
10-Q2015-05-07fiscal Q1 201525500001104659-15-035661
10-K2015-03-10fiscal FY 2014271150001047469-15-001908
10-Q2014-11-10fiscal Q3 201425660001104659-14-078975
10-Q2014-08-12fiscal Q2 201425670001104659-14-059931
10-Q2014-05-12fiscal Q1 201423560001104659-14-037619
10-K2014-03-13fiscal FY 2013251230001047469-14-002320
10-Q2013-11-06fiscal Q3 201323720001104659-13-081698
10-Q2013-08-12fiscal Q2 201322710001104659-13-062514

Inspect the source

Entity
Esperion Therapeutics, Inc. / CIK 0001434868
Captured
2026-09-21T17:19:05.322Z
SEC response SHA-256
c855d6a6c2d879a88675aebb590fdc9935826605a25a04ffeec1282218bce6bf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001434868.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))